Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome

NCT05933603 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT05933603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05933603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 29, 2023
Completion date
June 30, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome, obstructive sleep apnea